tranexamic acid has been researched along with Chronic Kidney Failure in 9 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ligneous conjunctivitis is a rare severe conjunctivitis characterised by fibrin-rich, 'woody', pseudomembranes on the tarsal conjunctiva complicated by congenital hypoplasminogenaemia." | 5.40 | Tranexamic acid-induced ligneous conjunctivitis with renal failure showed reversible hypoplasminogenaemia. ( Izumi, N; Potts, LB; Song, Y; Yoshida, A, 2014) |
| "Colonic angiodysplasias are a common source of gastrointestinal bleeding in patients with end-stage renal disease (ESRD)." | 5.30 | Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. ( Lavre, J; Sabovic, M; Vujkovac, B, 1998) |
| " In 16 episodes of bleeding TXA was used (in a dosage of 20 mg intravenously, followed for the next 4 weeks by 10 mg/kg/48 h orally), whereas in 20 other cases of bleeding, TXA was not used." | 2.71 | Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. ( Lavre, J; Sabovic, M; Vujkovac, B, 2003) |
| " TXA in the dosage used was biologically active, since a significant decrease in plasminogen and D-dimer were found in both groups." | 2.71 | The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. ( Cernelc, P; Lavre, J; Sabovic, M; Salobir, B; Vujkovac, B; Zupan, I; Zupan, IP, 2005) |
| "Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent commonly used for the prevention and treatment of bleeding disorders." | 2.55 | Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature. ( Chow, KM; Kwan, BC; Leung, CB; Li, PK; Ma, TK; Szeto, CC, 2017) |
| "Ligneous conjunctivitis is a rare severe conjunctivitis characterised by fibrin-rich, 'woody', pseudomembranes on the tarsal conjunctiva complicated by congenital hypoplasminogenaemia." | 1.40 | Tranexamic acid-induced ligneous conjunctivitis with renal failure showed reversible hypoplasminogenaemia. ( Izumi, N; Potts, LB; Song, Y; Yoshida, A, 2014) |
| "Colonic angiodysplasias are a common source of gastrointestinal bleeding in patients with end-stage renal disease (ESRD)." | 1.30 | Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. ( Lavre, J; Sabovic, M; Vujkovac, B, 1998) |
| "Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions." | 1.26 | Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. ( Andersson, L; Eriksson, O; Hedlund, PO; Kjellman, H; Lindqvist, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Y | 1 |
| Izumi, N | 1 |
| Potts, LB | 1 |
| Yoshida, A | 1 |
| Revollo, JY | 1 |
| Cuffy, MC | 1 |
| Witte, DP | 1 |
| Paterno, F | 1 |
| Alloway, RR | 1 |
| Woodle, ES | 1 |
| Ma, TK | 1 |
| Chow, KM | 1 |
| Kwan, BC | 1 |
| Leung, CB | 1 |
| Szeto, CC | 1 |
| Li, PK | 1 |
| Kimura, SI | 1 |
| Odawara, J | 1 |
| Aoki, T | 1 |
| Yamakura, M | 1 |
| Takeuchi, M | 1 |
| Watanabe, Y | 1 |
| Matsue, K | 1 |
| Sabovic, M | 3 |
| Lavre, J | 3 |
| Vujkovac, B | 3 |
| Zupan, IP | 1 |
| Salobir, B | 1 |
| Zupan, I | 1 |
| Cernelc, P | 1 |
| Mezzano, D | 1 |
| Panes, O | 1 |
| Muñoz, B | 1 |
| Pais, E | 1 |
| Tagle, R | 1 |
| González, F | 1 |
| Mezzano, S | 1 |
| Barriga, F | 1 |
| Pereira, J | 1 |
| Andersson, L | 1 |
| Eriksson, O | 1 |
| Hedlund, PO | 1 |
| Kjellman, H | 1 |
| Lindqvist, B | 1 |
1 review available for tranexamic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Blood Loss, Surgic | 2017 |
3 trials available for tranexamic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients.
Topics: Aged; Antifibrinolytic Agents; Combined Modality Therapy; Female; Gastrointestinal Hemorrhage; Hemos | 2003 |
The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
Topics: Aged; Antifibrinolytic Agents; Blood Platelets; Erythropoietin; Female; Fibrin Fibrinogen Degradatio | 2005 |
Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
Topics: Antifibrinolytic Agents; Bleeding Time; Fibrinolysis; Hemostasis; Humans; Kidney Failure, Chronic; P | 1999 |
5 other studies available for tranexamic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Tranexamic acid-induced ligneous conjunctivitis with renal failure showed reversible hypoplasminogenaemia.
Topics: Administration, Oral; Aged; Conjunctivitis; Dose-Response Relationship, Drug; Drug Administration Sc | 2014 |
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu | 2015 |
Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
Topics: Aged; Aortic Aneurysm; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Kidney Failure, | 2009 |
Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient.
Topics: Angiodysplasia; Antifibrinolytic Agents; Colonic Diseases; Gastrointestinal Hemorrhage; Humans; Kidn | 1998 |
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
Topics: Biological Availability; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; Glomerulonephriti | 1978 |